Ciraparantag acetate 是一种抗凝逆转剂，是一种小分子，专门设计用于通过电荷-电荷相互作用与普通肝素和低分子量肝素非共价结合。它显示出与直接口服抗凝剂 (DOAC) 相似的结合特性。

Ciraparantag acetate, an anticoagulant reversal agent, is a small molecule specifically designed to bind noncovalently by charge-charge interaction to unfractionated heparin and low-molecular-weight heparin. It shows binding characteristics that are similar to those of direct oral anticoagulants (DOACs).

1644388-83-9

C24H52N12O4

572.75

Ciraparantag acetate(1438492-26-2 Free base);Ciraparantag acetate

DMSO:65 mg/ml (113.49 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years